Back to Rankings

XGN

ExagenA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
XGN vs peer average
95/100
XGN vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · C 1 · D 2 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MXCT is the first available peer comparator.

The closest listed peer candidate by business adjacency among the packet names, but still a loose comp because MaxCyte is more life-science tools/platform oriented than diagnostic testing focused.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMXCTMaxCyte
XGN
Exagen
MXCT
MaxCyte
Grade
A
F
Momentum
95
19
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs MXCT

XGN / MXCT
Grade Position
Above peers
XGN vs. peer average (A vs. D)
95/100
Momentum
95
XGN
Value
41
XGN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XGN
1
MXCT
MXCT
F
20/100
+4
2
BDTX
BDTX
A
100/100
Even
3
GNLX
GNLX
D
40/100
+3
4
ONCY
ONCY
F
20/100
+4
5
ENGN
enGene Therapeutics Inc Common
B
80/100
+1
MXCT is the first peer returned for this comparison set.